These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 27151573)

  • 1. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G; Müller A; Biebermann H
    J Mol Endocrinol; 2016 Jul; 57(1):R59-80. PubMed ID: 27151573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
    Ferré S; Casadó V; Devi LA; Filizola M; Jockers R; Lohse MJ; Milligan G; Pin JP; Guitart X
    Pharmacol Rev; 2014; 66(2):413-34. PubMed ID: 24515647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History and biological significance of GPCR heteromerization in the neuroendocrine system.
    Tadagaki K; Jockers R; Kamal M
    Neuroendocrinology; 2012; 95(3):223-31. PubMed ID: 22156565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Techniques for Studying Oligomer Formations of G-Protein-Coupled Receptors Using Mammalian and Yeast Cells.
    Nakamura Y; Ishii J; Kondo A
    Curr Med Chem; 2016 May; 23(16):1638-56. PubMed ID: 27052183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of G protein-coupled receptor heteromers in endocrine systems.
    Jonas KC; Hanyaloglu AC
    Mol Cell Endocrinol; 2017 Jul; 449():21-27. PubMed ID: 28115188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomerization of G protein-coupled receptors: Still doubted?
    Ferré S; Ciruela F; Casadó V; Pardo L
    Prog Mol Biol Transl Sci; 2020; 169():297-321. PubMed ID: 31952690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPCR heteromers: An overview of their classification, function and physiological relevance.
    Dale NC; Johnstone EKM; Pfleger KDG
    Front Endocrinol (Lausanne); 2022; 13():931573. PubMed ID: 36111299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional crosstalk between GPCRs: with or without oligomerization.
    Prezeau L; Rives ML; Comps-Agrar L; Maurel D; Kniazeff J; Pin JP
    Curr Opin Pharmacol; 2010 Feb; 10(1):6-13. PubMed ID: 19962942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.
    Cottet M; Albizu L; Perkovska S; Jean-Alphonse F; Rahmeh R; Orcel H; Méjean C; Granier S; Mendre C; Mouillac B; Durroux T
    Curr Opin Pharmacol; 2010 Feb; 10(1):59-66. PubMed ID: 19896898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dynamics of GPCR Oligomerization and Their Functional Consequences.
    Sleno R; Hébert TE
    Int Rev Cell Mol Biol; 2018; 338():141-171. PubMed ID: 29699691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.
    Smith NJ; Milligan G
    Pharmacol Rev; 2010 Dec; 62(4):701-25. PubMed ID: 21079041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Proteoliposome High-Content Analysis Reveals Differences in the Homo-Oligomerization of GPCRs.
    Walsh SM; Mathiasen S; Christensen SM; Fay JF; King C; Provasi D; Borrero E; Rasmussen SGF; Fung JJ; Filizola M; Hristova K; Kobilka B; Farrens DL; Stamou D
    Biophys J; 2018 Jul; 115(2):300-312. PubMed ID: 30021106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions.
    Fuxe K; Marcellino D; Borroto-Escuela DO; Frankowska M; Ferraro L; Guidolin D; Ciruela F; Agnati LF
    J Recept Signal Transduct Res; 2010 Oct; 30(5):272-83. PubMed ID: 20684666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the role of heteroreceptor complexes in the central nervous system.
    Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
    Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond structure: emerging approaches to study GPCR dynamics.
    Gusach A; Maslov I; Luginina A; Borshchevskiy V; Mishin A; Cherezov V
    Curr Opin Struct Biol; 2020 Aug; 63():18-25. PubMed ID: 32305785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetry of GPCR oligomers supports their functional relevance.
    Maurice P; Kamal M; Jockers R
    Trends Pharmacol Sci; 2011 Sep; 32(9):514-20. PubMed ID: 21715028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
    Seyedabadi M; Ghahremani MH; Albert PR
    Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Di/oligomerization of GPCRs-mechanisms and functional significance.
    Rivero-Müller A; Jonas KC; Hanyaloglu AC; Huhtaniemi I
    Prog Mol Biol Transl Sci; 2013; 117():163-85. PubMed ID: 23663969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.